A new AI-based imaging solution for children with suspected tumors
A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric Diseases
This study is testing a new, quieter imaging method using AI to see if it can make it easier and safer for kids suspected of having tumors to get the scans they need.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 35 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Ruijin Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT06709690 on ClinicalTrials.gov |
What this trial studies
This study investigates the feasibility of using deep learning-assisted rapid silent PET/MR imaging specifically for pediatric patients. It aims to overcome the challenges of traditional PET/MR imaging by incorporating flexible coils and silent sequences to enhance comfort and reduce the radiation dose. The goal is to provide a quick and effective imaging solution for children suspected of having malignant tumors, ensuring a more pleasant experience during the examination.
Who should consider this trial
Good fit: Ideal candidates are children aged 0 to 18 years who exhibit clinical symptoms suggestive of malignant tumors and require PET/MR imaging.
Not a fit: Patients with severe illnesses, claustrophobia, or metal implants that prevent them from undergoing the imaging procedure may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the comfort and safety of imaging procedures for pediatric patients.
How similar studies have performed: While the use of AI in imaging is gaining traction, this specific approach combining silent PET/MR for pediatric applications is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Children who have clinical symptoms and are suspected of having malignant tumors after being evaluated by clinical pediatricians and require 18F-FDG PET/MR examination to further clarify their conditions. 2. Signed and dated informed consent form 3. Commit to complying with the research procedures and cooperate in the implementation of the entire research process. 4. No gender restriction, aged between 0 and 18 years old. Exclusion Criteria: 1. Patients with serious illnesses that researchers consider unsuitable for participation in this clinical study. Such as severe heart and lung failure, severe bone marrow suppression, severe liver and kidney dysfunction, etc. 2. Patients with severe claustrophobia，epileptic seizures, respiratory distress who cannot lie down, and patients with mental anomalies who are unable to cooperate. 3. Patients with metal implants such as pacemakers, artificial metal heart valves, and neurostimulators in their bodies. 4. Non-compliant person.
Where this trial is running
Shanghai, Shanghai Municipality
- China, Shanghai Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine — Shanghai, Shanghai Municipality, China (Recruiting)
Study contacts
- Study coordinator: Jiajia Hu
- Email: jiajiahu@shsmu.edu.cn
- Phone: 13524945287
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.